website marketing – From The Desk Of Mike Stewart http://fromthedeskofmikestewart.com/ Tue, 02 Aug 2022 03:26:14 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://fromthedeskofmikestewart.com/wp-content/uploads/2021/06/icon-53.png website marketing – From The Desk Of Mike Stewart http://fromthedeskofmikestewart.com/ 32 32 Regulatory Advances for Prostate and Kidney Cancer Imaging https://fromthedeskofmikestewart.com/regulatory-advances-for-prostate-and-kidney-cancer-imaging/ Mon, 01 Aug 2022 22:51:00 +0000 https://fromthedeskofmikestewart.com/regulatory-advances-for-prostate-and-kidney-cancer-imaging/ Melbourne, Australia, August 1, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports regulatory progress for the Company’s leading prostate and kidney cancer imaging programs in the Asia Pacific (APAC) Region of operation, including progress in the main market of China with its strategic partner Grand Pharmaceutical Group Limited (Grand Pharma). […]]]>

Melbourne, Australia, August 1, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports regulatory progress for the Company’s leading prostate and kidney cancer imaging programs in the Asia Pacific (APAC) Region of operation, including progress in the main market of China with its strategic partner Grand Pharmaceutical Group Limited (Grand Pharma).

TLX591-CDx (Iluccix®) for prostate cancer imaging

  • China: An Investigational New Drug (IND) application was filed by Telix’s partner in Greater ChinaGrand Pharma, at the National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) – and accepted for review – for a pivotal Phase III registrational study that will link to the approval of Illuccix by the United States Food and Drug Administration (FDA).
  • South Korea: As previously reported, an imported New Drug Application (NDA) was submitted by Telix’s partner in South KoreaDuChemBio Co, Ltd. (DuChemBio), to the Ministry of Food and Drug Safety (MFDS) for TLX591-CDx (Illuccix®Kit for the preparation of 68Ga-PSMA-11), a radiopharmaceutical targeting prostate-specific membrane antigen (PSMA) for imaging prostate cancer using positron emission tomography (PET).1

TLX250-CDx for Kidney Cancer Imaging

  • China: An IND application has been submitted by Grand Pharma to the NMPA CDE (and accepted for review) for a pivotal Phase III registrational study that will link to Telix’s global Phase III “ZIRCON” trial in the TLX250-CDx (89Zr-girentuximab), for imaging renal cell carcinoma (RCC) with positional emission tomography.

Phase III bridging studies of TLX591-CDx and TLX250-CDx must provide “additional” data in a Chinese-only population to establish that the efficacy of these investigational products is equivalent in Chinese and Western populations. Both studies are planned to be multicentre, enrolling approximately 100 patients.

“Together with our partners, we are pleased to announce the achievement of these important regulatory milestones, including the submission of a first NDA for PSMA imaging in Asia. Additionally, we have made significant progress in China, following an extensive consultation process with the NMPA, and have filed our first IND applications in this important market. The expertise and strong support of our partners Grand Pharma and DuChemBio enabled an efficient process and the achievement of these milestones on time,” said Dr. David N Cade, CEO of Telix Asia Pacific. “The Asia Pacific The region represents a major market opportunity, driven by rising cancer incidence rates and investment in the installation of PET/CT cameras in markets such as China and India. We are committed to bringing targeted imaging and radiation therapy to patients in need throughout the region. »

About prostate and kidney cancer in the Asia Pacific Region

The Asia Pacific The region contains about one-third of the world’s male population and includes many countries whose populations are aging or increasingly adopting more affluent “Western-style” lifestyles, with the two main demographic trends leading to rising rates of cancer incidence. Consequently, the incidence of prostate cancer is increasing in many parts of the region.

In South Koreamore than 13,000 men are diagnosed with prostate cancer each year.2

In China, 115,000 men are diagnosed with prostate cancer each year, increasing by approx. 6% each year and 73,000 people are diagnosed with renal cell carcinoma each year.

In line with government policy supporting wider geographic access to nuclear medicine, the number of PET/CT cameras installed in China should reach 1,110 at the end of 2022, compared to 133 in 2010.3

About Iluccix® (TLX591-CDx)

Illuccix (TLX591-CDx) is a preparation for positron emission tomography (PET) imaging of prostate cancer, targeting prostate-specific membrane antigen (PSMA), a protein overexpressed on the surface of more than 90% of primary and metastatic prostate cancer cells. Illuccix allows PSMA-11 to be labeled with the radionuclide Ga-68 directly before injection by healthcare professionals. After preparation of the radiopharmaceutical and injection into the patient, the PSMA-positive lesions are localized by PET imaging.

Illuccix has been approved by the United States Food and Drug Administration (FDA),4 and by the Australian Therapeutic Goods Administration (TGA).5 Telix is ​​also pursuing marketing authorization applications for this experimental candidate in Europe6 and Canada.seven

About the TLX250-CDx

TLX250-CDx (89Zr-girentuximab) is an investigational product developed by Telix with the aim of non-invasively detecting clear cell kidney cancer in patients with “undetermined renal masses” (IDMR), usually identified on the basis of CT scan (CT) or magnetic resonance imaging. (MRI) and are a growing medical dilemma as more tests are performed and more MDRIs are identified.

Grentuximab is a monoclonal antibody that targets carbonic anhydrase IX (CA9), a cell surface target highly expressed in several human cancers, including kidney, lung and esophageal cancers. In July 2020the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy (BT) designation to TLX250-CDx,8 reflecting the significant unmet clinical need to improve the diagnosis and staging of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer.

About Telix Pharmaceuticals Limited

Telix is ​​a biopharmaceutical company specializing in the development and marketing of diagnostic and therapeutic products using targeted molecular radiation (MTR). Telix is ​​headquartered in Melbourne, Australia with international operations in Belgium, Japan, Swissand United States. Telix is ​​developing a portfolio of clinical-stage products that address significant unmet medical needs in oncology and rare diseases. Telix is ​​listed on the Australian Securities Exchange (ASX: TLX). For more information, visit www.telixpharma.com and follow Telix on Twitter (@TelixPharma) and LinkedIn.

Telix Investor Relations

Ms Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Corporate Communications and Investor Relations
E-mail: [email protected]

This announcement has been authorized for publication by Dr. Christian BehrenbruchManaging Director and Group Chief Executive.

Legal Notice

This announcement may include forward-looking statements relating to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “outlook”, “forecast” and “guidance”, or other similar words. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed. or implied by these forward-looking statements. research statements. Forward-looking statements are based on the Company’s good faith assumptions about financial, market, regulatory and other risks and considerations that exist and affect the Company’s business and operations in the future, and there can be no assurance that the either of the hypotheses turn out to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements regarding: the initiation, timing, progress and results of Telix’s preclinical and clinical studies, and Telix’s research and development of Telix; Telix’s ability to advance product candidates, enroll in and complete clinical studies, including multinational clinical trials; the timing or likelihood of regulatory filings and approvals, manufacturing activities and product marketing activities; the commercialization of Telix’s product candidates, if or when they have been approved; estimates of Telix’s expenses, future revenues and capital needs; the financial performance of Telix; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may differ materially from those expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. You should read this announcement together with our risk factors, as disclosed in our latest reports filed with the ASX or on our website.

To the fullest extent permitted by law, Telix disclaims any obligation or undertaking to publicly update or revise any forward-looking statements contained in this announcement, whether as a result of new information, future developments or a change in expectations or assumptions.

The Telix Pharmaceuticals and Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates (all rights reserved).

1 ASX Disclosure July 21, 2022.
2 Globocan 2021.
3 Search Goetz Partners 2020.
4 ASX Disclosure December 20, 2021.
5 ASX Disclosure November 2, 2021.
6 ASX Disclosure December 10, 2021.
seven ASX Disclosure December 16, 2020.
8 ASX Disclosure July 1, 2020.

SOURCE Telix Pharmaceuticals Limited

]]>
Vanguard Online Marketing Creates Effective Website Designs for SC Businesses https://fromthedeskofmikestewart.com/vanguard-online-marketing-creates-effective-website-designs-for-sc-businesses/ Fri, 29 Jul 2022 15:36:07 +0000 https://fromthedeskofmikestewart.com/vanguard-online-marketing-creates-effective-website-designs-for-sc-businesses/ Hilton Head Island, SC – Vanguard Online Marketing, a full-service digital marketing agency based in Bluffton, SC, provides the most effective website design, helping SC businesses stay on top of their game. The leading digital marketing company offers Web Design Services South Carolina suitable for every type of business. Vanguard Online Marketing encourages businesses to […]]]>

Hilton Head Island, SC – Vanguard Online Marketing, a full-service digital marketing agency based in Bluffton, SC, provides the most effective website design, helping SC businesses stay on top of their game.

The leading digital marketing company offers Web Design Services South Carolina suitable for every type of business. Vanguard Online Marketing encourages businesses to improve their websites to stand out from their competitors.

Having designed hundreds of websites for different clients, Vanguard Online Marking adheres to their core values ​​which include innovation and creativity. Vanguard Online Marketing’s website development team knows what Google is looking for when it comes to ranking, simplicity, and format.

“Businesses need a well-designed site that will not only attract customers, but also retain them. Vanguard Online Marketing is the web design expert and will provide every business with the traffic-driving website they need to grow their online business,” says VOM.

The Best Website Designer in SC is updated with the latest website designs and offers excellent and fast service. Vanguard Online Marketing further claims that its services are competitive and never give up on quality.

On top of that, VOM emphasizes that building a relationship with its customers is a top priority. They say, “We listen to our customers and work with them to help them achieve their business goals. For us, web design is never done until customers are completely satisfied. Then, using different website designs, we customize the website design according to the needs of our clients, giving it the look it needs to attract their respective clientele.

Otherwise, Cutting-edge online marketing brings together professionals from different areas of digital marketing. The team is led by digital marketing expert Ed Gelb, who has 35 years of business experience, including a top-level digital marketing education. He is joined by an equally talented team of experts in website development, digital marketing, search engine optimization and other online strategies.

Along with website design and development, Vanguard Online Marketing also offers website maintenance services, which are equally important. In addition, they also offer SEO services (search engine optimization) and other digital marketing services including email marketing, content marketing, social media marketing, paid advertising , lead generation services, and video and multimedia marketing through video, podcasting, and webinars.

To learn more about web design in Hilton Head and Bluffton, SC, interested parties can visit their website at https://vanguardonlinemarketing.com/. Vanguard Online Marketing also offers a free consultation. They can call 843-422-7458 or send their email to [email protected] or visit their office at 766 Cornplanters Court, South Bluffton, SC 29910.

###

For more information about Vanguard Online Marketing, contact the company here:

Cutting-edge online marketing
Edward Gelb
843-422-7458
[email protected]
“766 Cornplanters Court South
Bluffton, SC 29910″

]]>
Jiuzi Holdings Inc. Holds Business Conference and Acquires Potential Franchisees https://fromthedeskofmikestewart.com/jiuzi-holdings-inc-holds-business-conference-and-acquires-potential-franchisees/ Tue, 26 Jul 2022 12:00:00 +0000 https://fromthedeskofmikestewart.com/jiuzi-holdings-inc-holds-business-conference-and-acquires-potential-franchisees/ HANGZHOU, China, July 26, 2022 /PRNewswire/ — Jiuzi Holdings, Inc. (NASDAQ: JZXN; the “Company”), a leading New Energy Vehicle (NEV) dealership group under the “Jiuzi” brand in Chinaannounced today that it has successfully hosted a business conference (the “Conference”) at the Company’s headquarters in Hangzhou continue its ongoing efforts to expand its geographic presence through […]]]>

HANGZHOU, China, July 26, 2022 /PRNewswire/ — Jiuzi Holdings, Inc. (NASDAQ: JZXN; the “Company”), a leading New Energy Vehicle (NEV) dealership group under the “Jiuzi” brand in Chinaannounced today that it has successfully hosted a business conference (the “Conference”) at the Company’s headquarters in Hangzhou continue its ongoing efforts to expand its geographic presence through cooperation with other leading electric vehicle brands in China.

The conference was held in the presence of Kunshan Baoneng Auto Sales Co., Ltd. (“Kunshan Baoneng”), the subsidiary of Baoneng Auto Group Ltd. (“Baoneng Auto”), with which the Company signed a letter of intent (the “LOI”) signed in June to allow the Company to distribute Baoneng Auto’s “Youbaoli” brand electric cars in zhejiang province. This conference served as a follow-up co-marketing campaign by the two companies to attract potential franchisees to join JZXN, and gave Kunshan Baoneng the opportunity to introduce its new electric vehicle model as well as its brand. . At the end of the conference, eight prospective franchisees entered into the Franchise Letters of Intent (the “Franchise LOI”) with the Company, among which six prospective Franchisees paid the deposit to the Company immediately after execution of the franchising letter of intent.

“We are delighted to see that our new marketing strategy has proven successful,” said Mr. Shuibo Zhang, CEO of Jiuzi Holdings, Inc. “We are looking for collaboration with premium NEV start-ups, such as Baoneng and Aiways , to explore On the one hand, our competitive advantages in national distribution, state-of-the-art terminal sales management and supply chain management can help NEV start-ups rapidly expand terminals of retailing profitably through our established franchise On the other hand, with the help of the brand prestige of our car manufacturing partners, we can easily attract more and more decent potential franchisees. I think this win-win model could foster business synergies for both companies.

About Jiuzi Holdings, Inc.

Jiuzi Holdings, Inc., headquartered in Hangzhou, Chinaand established in 2017, franchises and operates retail stores under the “Jiuzi” brand to sell New Energy Vehicles (“NEV”) in third- and fourth-tier cities in China. The Company mainly sells battery electric vehicles and sources NEVs from more than twenty NEV manufacturers. It has 51 operating franchise stores and one company-owned store. For more information, visit the Company’s website at http://www.zjjzxny.cn/.

Forward-looking statements

All statements other than statements of historical facts in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. They are based on current expectations and projections regarding future events and financial trends that the Company believes could affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the ‘Offer is carried out. Investors can identify these forward-looking statements by words or phrases such as “may”, “will”, “expect”, “anticipate”, “aim”, “estimate”, “has intention to”, “plans”, “believes”, “potential”, “continues”, “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent events, circumstances or changes in its expectations, except as required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that these expectations will prove to be correct. The Company cautions investors that actual results may differ materially from anticipated results and encourages investors to consider other factors that could affect its future results in the Company’s registration statement and other filings with the SEC. .

For more information please contact:

Stephen Tong
E-mail: [email protected]

SOURCE Jiuzi Holdings, Inc.

]]>
Leaders from across sports share challenges and strategies for selling the best seats at their venues https://fromthedeskofmikestewart.com/leaders-from-across-sports-share-challenges-and-strategies-for-selling-the-best-seats-at-their-venues/ Mon, 25 Jul 2022 10:23:02 +0000 https://fromthedeskofmikestewart.com/leaders-from-across-sports-share-challenges-and-strategies-for-selling-the-best-seats-at-their-venues/ The new KPMG Ignition – DC Innovation Suite is a mega-suite transformed into a uniquely immersive client and business development experience at Capital One Arena. Washington Capitals Selling high-end inventory for sports venues is more challenging than ever, due to competition for people’s time, snowballing societal and demographic changes, and smaller sales teams. Eight industry […]]]>

The new KPMG Ignition – DC Innovation Suite is a mega-suite transformed into a uniquely immersive client and business development experience at Capital One Arena. Washington Capitals

Selling high-end inventory for sports venues is more challenging than ever, due to competition for people’s time, snowballing societal and demographic changes, and smaller sales teams. Eight industry professionals gave SBJ their perspective on the challenges of premium sales in 2022 and what they are doing differently to face the moment.

Arich Berghammer, Senior Vice President of Revenue and Growth, Global ASM
Nick Bisho, Senior Vice President, Sales, QuintEvents
Jack Bye, Executive Vice President, Learfield Amplify
Kevin Camper, Director of Sales, Speedway Motorsports
Kirsten Corio, Managing Director, Ticketing, Hospitality and Media, USTA
Lorin Fantaskey, Vice President, Guest Services and Operations, Suites, Monumental sports and entertainment
Sarah Minkoff, Managing Director, University of Wisconsin, Legends
Jonathan White, Director, Premium Hospitality, San Jose Sharks

What are the biggest challenges to selling premium in 2022?

BERGHAMMER: The biggest challenge was understanding the impact of the pandemic on our customers and adjustments to expectations during a live event. Now more than ever, we are seeing strong demand and our customers continue to want the best experiences and are looking for even bigger selections and elevated options. This has given us the ability to implement programs ahead of schedule, constantly listening, always refining and evolving.

BICHO: The biggest challenge we’ve faced has been meeting the unprecedented demand we’ve seen for a premium experience at a sporting event, particularly around our core programs with the Kentucky Derby, Formula 1 and the NBA.

BYE: The best inventory has already been selected by long-time donors. Our representatives try to sell what is considered less desirable and, given the level of investment, usually opt for general seats. Inflation wreaks havoc on disposable income – of consumers and businesses. Several of our GMs and premium sellers have said that business prospects need to cut back and that premium tickets and tickets in general are one of the first expenses they cut back on.

CAMPER: Ensure experience exceeds expected value, especially with the challenges of the current economic environment (inflated F&B costs, staff shortages, travel expenses). Ensure that the experience is equal to or better than that offered by the local/regional competition.

CORIO: Our main challenge is not having enough premium inventory to meet the high demand. It’s a good deal to have, but we would like to have more suites and premium seats to offer during the second week of the US Open, and especially during the quarterfinals, semifinals and finals.

FANCY : We are in a rapidly changing digital world and premium customers do not want long communications; they want easy, quick and simple solutions to their hospitality needs. The approach to sales must evolve to continue to be successful in our industry. Buying online suites, creating unique experiences for social media influencers, digital marketing on the go – it’s already in our planning.

MINKOFF: The last few years have permanently transformed consumer expectations and needs. It’s hard to decipher what the trends are in reaction to post-pandemic life and what trends will be lasting. We had to put more emphasis on personalization and find a way to reinstate the importance and appeal of an in-person experience. Adapting and updating our sales process to accommodate a more virtual environment has also been a unique challenge.

WHITE: After the pandemic, we are seeing a few trends. On the one hand, there is a general hesitation in the market for long-term commitments. Just a few months ago, health and safety protocols were changing on a weekly, and sometimes daily basis, creating a more cautious buyer. This last point probably goes without saying, but organizations are also much more budget conscious. Much more attention is paid to the use of tickets, etc., to ensure a real return on investment.

What do you do differently when it comes to selling premium successfully?

BERGHAMMER: We’ve always believed that premium is about experience, not just getting a better seat. We understand our customers and further personalize the on-site experience based on their expectations. It starts with first contact (login on the website or through a vendor), ticketing, parking and arrival, catering, access to elevated spaces and world-class interaction with the personal.

BICHO: Our focus from a premium perspective is not just the enterprise, but also the executive consumer and bucket list buyer. We channeled our resources into our e-commerce engine to create a reliable and seamless online user experience. This allows us to sell 24/7/365 and automatically sync buyers with a dedicated sales manager in one of our global offices.

BYE: Strategic open house events, showcasing premium spaces, including setting up spaces as they would be on matchdays for face-to-face meetings. Move current season ticket holders from regular seats to premium seats by letting them know that premium inventory is open through awareness campaigns. There is a bit of a reality to the perception that the bounty has run out when it hasn’t.

CAMPER: Leverage customer feedback to constantly improve our offerings, which has led to the creation of all-inclusive turnkey packages and the creation of new pricing tiers and experiences to meet the needs of a higher premium experience range and those looking for value. [Also] reminding current and potential customers that the fan experience and access is back and better than ever with more live music, driver access and pit/garage access. We’ve also ramped up marketing efforts to find more leads and promote options. We’re working harder than ever to ensure we provide creative and unique options to enhance the experience of current customers.

CORIO: We are investing more time in customer relationship development with a larger sales team. We did this to ensure we had quality conversations about the medium (Zoom, old fashioned phone call, etc.) and the timeline the prospect/customer wanted. Targeted and direct digital outreach to past attendees who resemble the profile of US Open hospitality buyers has been really effective. And, creating bespoke bucket-list-like experiences at the US Open with products like Courtside Premier has brought in a host of new, high-demanding customers.

FANCY : We are constantly innovating. In our recent partnership announcement with KPMG, we disrupted the traditional idea of ​​a suite by offering them daytime use for business development and innovation – in addition to evening hospitality. With a complete renovation of the suite, KPMG has transformed it into a state-of-the-art experience, with the latest technology serving as a meeting place for clients. This is the first such partnership, and more are expected.

MINKOFF: We create digital content in real time and deliver it to multiple touchpoints. The same lead receives an organized email, personal phone call, and targeted paid ad content within 24-48 hours. We also leverage web retargeting and geolocation to deliver content to prospects within a certain stadium range and nearby affluent zip codes, as well as leverage household income data using multiple technology partners .

WHITE: Starting last season, we transitioned our premium suite rentals to a digital-first experience, which was a huge shift in our premium sales process. Fans can now book suites, parking passes and dining options completely independently, which has been extremely well received by our fanbase. Going forward, we will continue to explore digital-focused benefits and packages in our premium retail product line.

]]>
Kim Kardashian sued by SKKN+ owners for trademark infringement https://fromthedeskofmikestewart.com/kim-kardashian-sued-by-skkn-owners-for-trademark-infringement/ Fri, 22 Jul 2022 22:02:46 +0000 https://fromthedeskofmikestewart.com/kim-kardashian-sued-by-skkn-owners-for-trademark-infringement/ Does all the press get good press? Not for Brooklyn-based skincare company Beauty Concepts using its SKNN+ brand. None other than Kim Kardashian is the subject of another controversial conversation. With the recent launch of her skincare brand SKKN By Kim, critics have accused Kardashian of stealing the “SKKN” name from black-owned beauty brands. Given […]]]>

Does all the press get good press? Not for Brooklyn-based skincare company Beauty Concepts using its SKNN+ brand. None other than Kim Kardashian is the subject of another controversial conversation. With the recent launch of her skincare brand SKKN By Kim, critics have accused Kardashian of stealing the “SKKN” name from black-owned beauty brands. Given Kardashian’s previous encounters with accusations of appropriating other cultures, the failure to rebrand her new venture comes as no shock. In 2019, the city of Kyoto urged Kardashian to rethink the name of its shapewear brand Kimono, explaining the cultural significance of the garment.

Consumers first compared SKKN By Kim to the existing brand SKN by Lori Harvey. Yet the public criticism has rocked social media and extended its reach to the courts, albeit with a completely different company, pitting Kardashian, her corporate entity Kimsaprincess Inc., against her cosmetics maker Coty, Inc., which owns a stake. 20% in Kardashian’s KKW. Beauty, v. Beauty Concepts LLC, a 4-year-old, Black, women-owned skincare company doing business as SKKN+, which opened a physical location after surviving the pandemic.

In a new trial at Eastern District of New York, Beauty Concepts vs. Kim Kardashian et al., 1:22-cv-03797 (EDNY) Beauty Concepts is suing for trademark infringement and unfair competition, reverse confusion, illegal deceptive acts and business practices in violation of New York Gen. Bus. Law §349-50 and other related claims against Kardashian and her co-defendants in connection with the SKKN by Kim trademark and use of the marks on goods and services which, according to the plaintiff, are “identical or closely related to the services offered by Beauty Concepts under [its own] SKKN+ brand.

Beauty Concepts began using the SKKN+ brand in August 2018 for its skincare products and services. Beauty Concepts says it learned of the defendants’ intention to launch a skincare line under the SKKN and/or SKKN BY KIM brand around July 2021 when Kardashian filed 17 trademark applications for SKKN BY KIM. On March 28, 2021, just two days before Kardashian filed its first “SKKN by Kim” applications, Beauty Concepts filed its own trademark application for “SKKN+”. Growing concerns over Kardashian’s entry into the market prompted Beauty Concepts to ask Kim and her partners “to drop their plans to use a brand that incorporates the most significant elements of Beauty Concepts’ SKKN+ brand, to know the letters ‘SKKN'”.

Prior to filing suit in the Eastern District, Beauty Concepts filed opposition proceedings before the USPTO’s Trademark Trial and Appeals Board in December 2021 to try to block four of the claims. defendants for the trademark SKKN BY KIM to be registered by the trademark office. In response, Kardashian’s attorneys attributed Beauty Concepts’ attempt to block Kardashian’s candidacy to “the misconception [that Beauty Concepts] holds the exclusive trademark rights to the term “skkn” for anything and everything related to beauty, cosmetics, hair or nails. Kardashian’s attorney went on to say that the descriptive nature of the mark does not warrant the exclusive rights, especially in light of the fact that “skkn” is just a misspelling of the term “skin.” .

Even with trademark applications delayed by oppositions, Beauty Concerns argues that the SKKN BY KIM on June 21st launch has already hurt small business. Mirroring fashion brand Rhode’s claims in the trademark lawsuit against Hailey Bieber’s recently launched skincare brand under the same name, Rhode-NYC, LLC v Rhodedeodato Corp. et al1:22-cv-05185 (SDNY) Beauty Concepts says Kardashian’s “prominent celebrity” status should “quickly eclipse[]”Beauty Concepts’ SKKN+, with Kardashian’s brand “on the verge of earning hundreds of millions of dollars in revenue under counterfeit SKKN brands.”

In addition to the likelihood that the defendants have already caused confusion due to the similarity between the marks and the goods and services they provide, Beauty Concepts argues that the defendants “further add to the likelihood of confusion” by “we[ing] and underline[ing] SKKN in their packaging and marketing. For example, “the trademark logo SKKN BY KIM also heavily emphasizes the term ‘SKKN’ and attenuates the words ‘by Kim'”, which “amplifies the likelihood of confusion between defendants’ trademark SKKN and SKKN + of Beauty Concepts brand.”

To succeed in its trademark infringement action, Beauty Concepts must establish that it owns a valid trademark entitled to protection; the defendants used the same or a similar mark in commerce in connection with the sale or advertising of goods or services without the consent of Beauty Concepts; and Defendants’ use is likely to create confusion as to Defendants’ affiliation, connection, or association with Beauty Concepts, or the origin, sponsorship, or endorsement of any goods, services, or activities defendants’ commercial activities by Beauty Concepts.

A likelihood of confusion between marks exists when the marks are so similar and the goods and/or services for which they are used are so related that consumers would mistakenly believe that they come from the same source. In order to determine whether there is a likelihood of confusion, marks are examined for similarities and differences. The extent of this similarity – whether based on sound, appearance and/or meaning – “may be sufficient to support a finding of likelihood of confusion, depending on the connection between the goods and/or services “. In addition, courts use several factors to guide their analyses. The second circuit, for example, analyzes the likelihood of confusion using the factors set out in Polaroid Corp. vs. Polarad Elecs. Corp., 287 F.2d 492 (2nd Cir. 1961). These factors include the strength of the senior user’s brand, similarity of brands, similarity of products or services, likelihood that the senior user will close the gap and expand into the product line of the junior user, junior user’s intention to adopt the mark, evidence of actual confusion, sophistication of buyers, quality of junior user’s goods or services and related goods and services.

Beauty Concepts says the inevitable result of SKKN by Kim in the beauty market is reverse confusion. Reverse confusion occurs when a large junior user saturates the market and their brand becomes more prominent than the senior brand. While this claim isn’t particularly common, it remains one of the biggest fears of small business owners, especially in the beauty and retail industries. Beauty Concepts asserts that consumers expect to “acquire defendants’ products bearing the infringing SKKN marks and/or services performed using such products from Beauty Concepts.” Accordingly, Defendants’ use of the allegedly infringing Marks “has and will continue to interfere with the ability of Beauty Concepts customers and potential customers to seek and find information about Beauty Concepts, its physical location, SKKN+ services and the SKKN+ website and online marketing.”

Beauty Concepts notes the defendants’ already well-followed social media accounts on platforms like Instagram, Twitter and TikTok, which consist exclusively of the word @skkn without the “by Kim” element. In fact, “many social media users mistakenly tagged Beauty Concepts’ @skknplus social media accounts when referencing” defendants’ products. Due to significant consumer confusion, “Beauty Concepts’ Internet presence has been overwhelmed by defendants’ advertising, and Beauty Concepts has experience[d] actual confusion in the form of individuals contacting Beauty Concepts to ask if they are affiliated with defendants and their infringing SKKN marks.

With the foregoing in mind, Beauty Concepts seeks an injunction restraining the defendants from continuing to use the allegedly infringing SKKN by Kim trademark, as well as damages. Since the lawsuit was filed, Kardashian’s attorneys have issued a statement denying the facts underlying the dispute, saying they “look forward to bringing our case to court.”

©2022 Norris McLaughlin PA, All Rights ReservedNational Law Review, Volume XII, Number 203

]]>
Flashback Technologies, Inc. Announces Appointment of Marcus Barkham as CEO and Change of Company Name https://fromthedeskofmikestewart.com/flashback-technologies-inc-announces-appointment-of-marcus-barkham-as-ceo-and-change-of-company-name/ Thu, 21 Jul 2022 18:45:00 +0000 https://fromthedeskofmikestewart.com/flashback-technologies-inc-announces-appointment-of-marcus-barkham-as-ceo-and-change-of-company-name/ BOSTON, July 21, 2022 /PRNewswire/ — Flashback Technologies Inc, an innovative digital healthcare company that uses artificial intelligence and machine learning technologies to turn basic physiological data into vital, life-changing vital signs, announced today today having named Marcus Barkham as CEO. Marcus Barkham, newly appointed CEO of Flashback Technologies. “Marcus brings over 20 years of […]]]>

BOSTON, July 21, 2022 /PRNewswire/ — Flashback Technologies Inc, an innovative digital healthcare company that uses artificial intelligence and machine learning technologies to turn basic physiological data into vital, life-changing vital signs, announced today today having named Marcus Barkham as CEO.

“Marcus brings over 20 years of senior executive experience in the healthcare and medical technology industries.,” said Vera TiceChairman of the Board of Directors. “With a strong clinical background, he adds a deep understanding of customer needs as well as a proven track record in commercializing and scaling healthcare businesses. We are delighted to have him on board and are excited about the new focus and direction he is already bringing to the organization.”

As part of this new corporate vision, Flashback Technologies has embarked on a company-wide name change to Impact Vitals, an initiative to more accurately reflect its mission and vision for the coming.

“I am incredibly honored to lead an exciting and innovative company whose advanced solutions reveal subtle and early changes in physiological state.” said Marcus BarkhamCEO of Impact Vitals.

Impact Vital’s algorithms deliver breakthrough insights into hydration and clinical fluid management never seen before. The fact that we can do this using standard, readily available medical and consumer sensor technology allows us to access and positively impact the lives of millions of people around the world. This is what drives us, and we hope that the name change and rebranding of the company will reflect our exciting new direction, strategy and direction. »

New branding, website, marketing materials and updates will be communicated over the coming weeks and months as exciting announcements are made.

About: Impact Vitals is a passionate and innovative digital health company focused on patient-centric software solutions.

Low levels of body fluids are a major cause of physiological deterioration. Due to the human body’s ability to perform compensatory mechanisms, standard changes in vital signs may remain stable until a sudden, precipitous collapse becomes evident. Late recognition of this situation results in leading causes of hospitalization, disability and death.

Existing deterioration monitoring tools have significant limitations. Our solutions provide a more powerful and faster indicator of physiological deterioration than any traditional vital sign or consumer-based indicator.

For any request, please send an e-mail: [email protected]

SOURCE Technologies Flashback

]]>
UPS students win national competition https://fromthedeskofmikestewart.com/ups-students-win-national-competition/ Tue, 19 Jul 2022 17:31:47 +0000 https://fromthedeskofmikestewart.com/ups-students-win-national-competition/ With what they learned in the classroom and the support and encouragement of their professors, students at Pittsburg State University won national victories this summer in a competition organized by Phi Beta Lambda, the largest commercial and technical organization in the world. PSU is home to an active chapter of PBL (the collegiate version of […]]]>

With what they learned in the classroom and the support and encouragement of their professors, students at Pittsburg State University won national victories this summer in a competition organized by Phi Beta Lambda, the largest commercial and technical organization in the world.

PSU is home to an active chapter of PBL (the collegiate version of Future Business Leaders of America) that regularly competes and attends conferences.

Two students – Sarah Clausen, a specialist in marketing and management, from Cherokee, Kansas, and Matthew Schmidt, a specialist in finance and business economics, from Easton, Kansas – won first place in a competition that attracted 900 university students from all over the United States.

Schmidt was in sports management and marketing, while Clausen’s win was in entrepreneurship concepts.

Clausen also won fourth place in social media marketing and sixth place in web design, both with classmate Wynter Jacobs, a marketing and management specialist from Pittsburgh. Their projects: a campaign on social networks for a beauty salon and a website for a thrift store.

“It’s really special to end my very last national leadership conference with this victory,” said Clausen, who is working on his MBA at Kelce College of Business.

She said PSU prepared her for the competition not only from an academic standpoint, but also with staff and faculty “who are extremely supportive of student organizations.”

“When we qualified for the Nationals, everyone was very helpful in our fundraising efforts,” she said. “Our advisor was particularly helpful in ensuring we would be financially able to go, helping to plan the trip and making sure we were ready for our competitions.”

It will also look great on her resume, she added, when she begins her job search soon.

In addition to his first place finish, Schmidt also earned third place in Financial Services and seventh place in Financial Concepts.

“The opportunity I was given to travel to Chicago via PSU PBL was transformational,” he said. “I participated in several professional events, I discovered new cultures and met new people at an international level.”

In total, PSU students participated in 15 events and won 14 trophies. The competitors were:

Amanda Becker, accounting major from Weir, Kansas
6e in accounting for professionals

Hannah Evans, accounting major from Shawnee, Kansas
Participation in accounting for professionals, accounting principles and macroeconomics

Spencer Grillot, accounting major from Oswego, Kansas
2n/a in cost accounting

Samuel Holman, computer information systems and economics specialist from Cassville, Missouri
5e in Microeconomics
5e in Macroeconomics
5e in programming concepts

Wyntr Jacobs, Marketing and Management Major from Pittsburgh
4e in business communication
4e in social media marketing
6e in web design

Learn more about Kelce College of Business.

]]>
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics https://fromthedeskofmikestewart.com/everest-medicines-announces-european-commission-grants-approval-of-kinpeygo-for-adults-with-primary-iga-nephropathy-to-our-partner-calliditas-therapeutics/ Mon, 18 Jul 2022 00:00:00 +0000 https://fromthedeskofmikestewart.com/everest-medicines-announces-european-commission-grants-approval-of-kinpeygo-for-adults-with-primary-iga-nephropathy-to-our-partner-calliditas-therapeutics/ Kinpeygo® (developed as NEFECON) is the first and only EMA-approved treatment for IgAN Everest Medicines has exclusive development and commercialization rights to NEFECON in Greater China, Singapore and South Korea SHANGHAI, July 17, 2022 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), today announced that our partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq […]]]>

Kinpeygo® (developed as NEFECON) is the first and only EMA-approved treatment for IgAN

Everest Medicines has exclusive development and commercialization rights to NEFECON in Greater China, Singapore and South Korea

SHANGHAI, July 17, 2022 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), today announced that our partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) has obtained conditional marketing authorization for Kinpeygo® (developed as NEFECON) from the European Commission for the treatment of primary immunoglobulin A (IgA) (IgAN) nephropathy in adults at risk of rapid disease progression with a urinary protein to creatinine ratio (UPCR) ≥1.5 g/gram.

In Europe, Kinpeygo is an orphan drug and the first and only approved treatment for IgAN, a rare and progressive autoimmune kidney disease with high unmet need, with more than 50% of patients potentially progressing to end-stage renal disease (IRT). The conditional marketing authorization applies in the 27 Member States of the European Union as well as in Iceland, Norway and Liechtenstein.

“We are delighted to receive formal approval for Kinpeygo in the European Economic Area as the first and only EMA-approved medicine for this disease,” said CEO Renée Aguiar-Lucander of Calliditas.

“We congratulate our partner Calliditas for achieving another major achievement in bringing this first disease therapy to more patients around the world living with the chronic disease,” said Kerry Blanchard, MD, PhD, CEO of Everest Medicines. “Primary IgAN is more common in Asia than anywhere else in the world with an even higher unmet demand for an innovative treatment and we hope to make this important therapy available soon in our region. »

Kinpeygo’s approval is based on efficacy and safety data from Part A of the pivotal Phase 3 NeflgArd study, an ongoing multicenter, randomized, double-blind, placebo-controlled study conducted to evaluate Kinpeygo 16 mg once daily orally versus placebo in adult patients with primary IgAN.

Everest reported in April 2022 that the results of reduction of proteinuria and stabilization of eGFR in a Chinese subpopulation after 9 months of treatment were consistent with the main results of part A of the NefIgArd study. These data will be included in the new drug application planned for China in the second half of this year.

About NEFECON

NEFECON is a delayed-release oral formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid activity that undergoes extensive first-pass metabolism. NEFECON has been designed as a 4 mg delayed release capsule and is enteric coated so that budesonide is released into the distal ileum. In June 2019Everest Medicines has entered into an exclusive, royalty-based license agreement with Calliditas, which gives Everest Medicines the exclusive rights to develop and commercialize NEFECON in mainland China, hong kong, Macau, Taiwan and Singapore. The agreement was extended in March 2022 include South Korea as part of the Everest Medicine territories.

About drugs Everest

Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address the critical unmet medical needs of patients in Asian markets. Everest Medicines’ management team has deep expertise and extensive experience in high quality clinical development, regulatory affairs, CMC, business development and operations in both China and with leading global pharmaceutical companies. Everest Medicines has built a portfolio of eleven potentially first-in-class or best-in-class molecules, many of which are in late-stage clinical development. The Company’s therapeutic areas of interest include oncology, autoimmune diseases, cardio-renal diseases and infectious diseases. For more information, visit their website at www.everestmedicines.com.

About Calliditas

Calliditas Therapeutics is a commercial-stage biopharmaceutical company based in Stockholm, Sweden focused on the identification, development and commercialization of new treatments in orphan indications, with an initial focus on kidney and liver diseases with significant unmet medical needs. Calliditas’ lead product, developed under the name Nefecon, obtained accelerated FDA approval under the trade name TARPEYOMT and conditional marketing authorization by the European Commission under the trade name KINPEYGO®.

Forward-looking statements:

This press release may contain statements that constitute forward-looking statements, including descriptions regarding the current intention, belief or expectations of the Company or its officers with respect to the Company’s business activities and financial condition. , which can be identified by terminology such as “will”, “expect”, “anticipate”, “future”, “intend”, “plan”, “believe”, “estimate”, ” trust” and similar statements. These forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, actual results may differ from those in forward-looking statements due to various factors and assumptions, such as future changes and developments in our business, the competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives is under no obligation and does not undertake to revise any forward-looking statements to reflect new information, future events or circumstances after the date of this press release, except as required by law. .

SOURCE Everest Medicines

]]>
20 tactics for marketing a law firm | Good2bSocial media https://fromthedeskofmikestewart.com/20-tactics-for-marketing-a-law-firm-good2bsocial-media/ Fri, 15 Jul 2022 23:00:22 +0000 https://fromthedeskofmikestewart.com/20-tactics-for-marketing-a-law-firm-good2bsocial-media/ [author: Noreen Fishman] Digital marketing can do amazing things for your law firm. The downside is that everyone knows it now. The online space is crowded with lawyers marketing their practice. So how can you increase your law firm’s online visibility and develop more business this year? Check out these 20 can’t-miss digital tactics for […]]]>

[author: Noreen Fishman]

Digital marketing can do amazing things for your law firm. The downside is that everyone knows it now. The online space is crowded with lawyers marketing their practice. So how can you increase your law firm’s online visibility and develop more business this year? Check out these 20 can’t-miss digital tactics for law firm marketing.

1. Work with a better SEO agency

In such a crowded search space, it’s essential that your website ranks for your key terms. If you’re working with a third party and you’re still not getting great organic rankings on Google, you need to re-evaluate. We suggest work with an agency specializing in the legal field. When choosing which agency to work with, ask to see their results in highly competitive spaces. Ask them to pull data from their customers’ search results and be sure to review their customers’ testimonials and case studies.

2. Post quality content regularly

Adding fresh content to your website is important for many reasons. That being said, only high-quality content will reap the rewards of search and traffic. This is another reason why it’s a good idea to have an SEO expert review new content with you. The best legal marketers add new pages to their site or blog every month.

3. Improve your website design to improve conversion rates

Your law firm’s website is a direct reflection of your firm. In order to maximize conversions and generate more leads, your website needs to outperform your competition. If you haven’t updated your website in the past two years, chances are it’s outdated. Invest in updating your site and, in doing so, keep conversion rate optimization (CRO) in mind. Small changes can make a big difference in the number of quality leads your website receives.

4. Go mobile-friendly

In 2022, having a mobile friendly the law firm’s website is imperative. Ultimately, any improvements you make to your website won’t have as much impact if they don’t help mobile users. Law firms without a mobile-friendly website are already lagging behind in the rankings, because Google moved to a mobile-first index.

5. Build stronger connections and engagement with video and animation

Video continues to conquer the digital space. We suggest you create a variety of videos, on many different topics. Not all need to be top of the line, but a few do. Videos designed to really “sell” your business need to be top quality, which means you may need to work with a professional.

If you are looking to join the ranks of lawyers who effectively use video to generate brand awareness and aid in business development, think about what these 10 lawyers and law firms do.

6. Run Paid Sponsored Content on LinkedIn’s Advertising Network

Sponsored Content is a form of native advertising on LinkedIn. The advertising platform offers fantastic ways to reach target audiences and target accounts. You can segment people by industry, geography, job title, company name, and more. Read our free eBook, The Law Firm’s Guide to Advertising on LinkedIn to learn how to optimize LinkedIn ad campaigns to ensure you get the best ROI.

7. Run retargeting campaigns on Facebook and Instagram

Any law firm running paid campaigns should include retargeting in their strategy. This is because people very rarely choose the first lawyer they searched for – they need to be reminded of your firm over time. Many companies run retargeting ads on other third-party platforms, but forget about Facebook and Instagram, which leaves a lot of exposure on the table.

8. Take advantage of local service ads on Google

Google says these ads “help you connect with people who search Google for the services you offer. Your ads will show to customers in your service area, and you only pay if a customer calls you directly. via ad.” This form of advertising takes the visitor directly to a profile page on Google, not to your website like traditional text ads. It’s cost effective because you only pay for the leads you get. marketing a law firm

9. Increase your paid search budget

If you want the best chance of generating leads and getting a strong return on investment (ROI), you need to make sure you have enough budget. Remember that a single case can be worth 6 or 7 digits. How many leads are needed to secure this case?

10. Improve your paid search landing pages

It’s a very common problem for businesses to have poor results with paid searches that can be attributed to ads linking to ineffective landing pages. Landing pages are an essential part of the conversion funnel and you should invest as many resources into them as you do into the other components of your paid advertising strategy.

11. Build a Martech Stack That Enables Your Marketing Team to Do More in Less Time

Marketing technology (Martech) enables business development and legal marketing teams to accomplish more in less time. From email marketing and automation to analytics and personalization, marketing technology has changed the way organizations and law firms scale their digital marketing engine and reap the rewards.

12. Get your law firm listed in well-ranked directories on Google

The “good” places to get listed are those that are highly ranked by Google. Check directories like Findlaw, SuperLawyers, Best Lawyers, etc., but only if they rank in the top 3 positions for the keywords you want to rank for. There will be associated costs, so you need to think about the return on investment.

13. Leverage chatbots to engage website leads in real time

It was a nice feature to have, but chatbots are essential these days. If your law firm’s digital marketing budget allows, look for smart chatbots that can control the dialog flow between the visitor and the chatbot.

14. Get more reviews for social proof and an SEO boost

If you don’t have enough Google reviews (or you have several but they aren’t exceptional), it could cost you dearly. Rest assured that researchers are researching what other clients have said about working with you. They want social proof of your claims. Make it a priority to improve your reviews – in quality and quantity.

15. Create a referral network

Naturally, your law firm wants to process the files that are in its wheelhouse. But what about tracks you can’t work on? Why not send them to another company and collect a referral fee? Work with other nearby businesses to network for these purposes. Note: Regulations on this can be complex, so make sure you understand what’s allowed in your state.

16. Create unique call tracking numbers for each campaign

Most companies understand this as a concept, but don’t take the time to really create all the different numbers required. Have unique call tracking numbers for organic SEO efforts, Google ads, Facebook ads, YouTube ads, directory listings, retargeting ads (unique for each platform), landing pages , etc. Extracting data on these numbers will help you better understand what is working and what is not so you can make better decisions and invest money in efforts that contribute to a positive ROI.

17. Create a microsite to track specific types of cases

It’s a good idea to target a specific area of ​​practice in order to differentiate yourself from competitors. If you are constantly looking for a certain type of case, you can create a specialized service microsite, with multiple pages and associated marketing campaigns. Specialty sites will convert at a much higher rate.

18. Approach the media with newsworthy stories

Generate public relations for your business by seeking opportunities to be cited in online publications and journals. A surefire way to do this is to approach journalists and build personal relationships with them. Pick up the phone, meet face to face and be a trusted partner instead of just a generic email in a reporter’s inbox.

19. Run advertisements for your law firm using OTT ads

If you’ve never heard of the term ‘OTT’, it’s time you figured out if you want to stay ahead of your competition. OTT stands for “Over the Top” and refers to how these ads bypass traditional cable and satellite TV to deliver video content. For example, ads that appear during your favorite Hulu show. They are more powerful than traditional TV ads because they allow marketers to target based on thousands of factors (most commonly geography, age, etc.). Users say they can deliver much more relevant ads and reduce budget waste.

20. Measure and optimize campaigns in real time.marketing a law firm

Real-time measurement and optimization is a real digital advantage. Measuring your marketing efforts is essential to ensure that your marketing strategy is getting things done and really contributing to your next generation of businesses. Check out our previous article on key marketing indicators to keep track.

Carry:

You don’t want to maintain the status quo in your business – you want to grow. This requires exploring new areas and constantly developing new strategies. It takes a constant and persistent presence to stay on top as a law firm, but there is no single online marketing strategy for law firms. Try these 20 tactics to help you expand your digital presence and win new leads.

]]>
ChemPoint® Announces New Collaboration with CFS North America and its Antioxidant Xtendra BHT https://fromthedeskofmikestewart.com/chempoint-announces-new-collaboration-with-cfs-north-america-and-its-antioxidant-xtendra-bht/ Mon, 11 Jul 2022 20:15:00 +0000 https://fromthedeskofmikestewart.com/chempoint-announces-new-collaboration-with-cfs-north-america-and-its-antioxidant-xtendra-bht/ ChemPoint® Announces New Collaboration with CFS North America and its Antioxidant Xtendra BHT Tweet that Rick HoenerGlobal Vice President and General Manager of ChemPoint, said, “We are excited to expand our supplier network to include CFS. Xtendra BHT, manufactured by Camlin Fine Sciences, Ltd., complements our current portfolio of preservatives and antioxidants and the CFS […]]]>

Rick HoenerGlobal Vice President and General Manager of ChemPoint, said, “We are excited to expand our supplier network to include CFS. Xtendra BHT, manufactured by Camlin Fine Sciences, Ltd., complements our current portfolio of preservatives and antioxidants and the CFS team is well positioned to meet the needs of today’s growing food and personal care markets. . This partnership will also meet the ever-changing needs of industrial applications that require a versatile, general-purpose antioxidant.

BHT is an antioxidant for food applications and helps provide transfer efficiency in fats and oils by imparting stability to baked goods, cereals and packaging materials. BHT is U.S. Food and Drug Administration (FDA) approved Kosher and Halal for use in food and food contact applications.

For industrial applications, BHT helps prevent degradation and discoloration of plastics, coatings, inks, and pigments, as well as stabilizes polymers when exposed to high temperatures and ultraviolet (UV) light. ).

ChemPoint offers technical expertise across multiple industries. With its marketing skills and deep understanding of customer needs, the company helps products like Xtendra BHT reach new markets and applications, supporting its growth.

Jennifer IgouManaging Director of CFS North America, LLC, added, “We see tremendous value in ChemPoint’s digital capabilities and are driving growth in new applications and market spaces. We look forward to leveraging the strengths of their organization to serve the North American market space with Xtendra BHT. a world leader in the production of traditional antioxidants, CFS is committed to producing the highest quality for our customers.”

For more information, visit chempoint.com.

About Camlin Fine Sciences®

CFS is a supplier of high quality ingredients including shelf life solutions, flavor ingredients, health and wellness products and performance chemicals. Based globally in Mumbai, Indiawith subsidiaries located in South AmericaLATAM, North America, Europe and China. With over thirty years of serving customers, we have learned that everyone has a unique need and therefore must require a unique solution. Our global expertise, local knowledge and technical know-how allow us to deliver what is required! For more information, please visit our website at camlinfs.com.

About ChemPoint®

ChemPoint.com, Inc., a wholly owned subsidiary of Univar Solutions Inc., is a unique distribution company providing marketing and sales services for specialty chemicals and fine chemicals in North America, Europe , the Middle East, Africa and Latin America. The company engages in exclusive product line relationships with leading manufacturers, providing tailored solutions to more than 90 supplier partners and more than 200 product lines worldwide. For more information, please visit chempoint.com.

About Univar Solutions

Univar Solutions (NYSE: UNVR) is a leading global distributor of chemicals and ingredients representing a leading portfolio of the world’s leading producers. With the largest private transport fleet and technical sales force in the industry, unparalleled logistics know-how, in-depth market and regulatory knowledge, formulation and recipe development, and digital leading edge, the company is well positioned to provide tailored solutions and value-added services to a wide range of markets, industries and applications. While fulfilling its purpose to help keep communities healthy, nourished, clean and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more about univarsolutions.com.

Forward-looking statements

This press release contains certain statements relating to future events and our intentions, beliefs, expectations and predictions for the future, which are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1933. Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are beyond the Company’s control. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations and assumptions. A detailed discussion of these factors and uncertainties is contained in the Company’s filings with the Securities and Exchange Commission. Potential factors that could affect these forward-looking statements include, among others: the ultimate geographic spread of the COVID-19 pandemic; the duration and severity of the COVID-19 pandemic; measures that may be taken by governmental authorities to address or otherwise mitigate the impact of the COVID-19 pandemic; the potential negative impacts of COVID-19 on the global economy and our customers and suppliers; the overall impact of the COVID-19 pandemic on our business, results of operations and financial condition; other fluctuations in general economic conditions, particularly in industrial production and our customers’ demands; material changes in the business strategies of producers or in the operations of our customers; increased competitive pressures, including from consolidation of competitors; significant changes in the prices, demand and availability of chemicals; our levels of indebtedness, the restrictions imposed by our debt securities and our ability to obtain additional financing if needed; the wide range of laws and regulations to which we are subject, including extensive environmental, health and safety laws and regulations; an inability to integrate the operations and systems of companies we acquire, including Nexeo Solutions, Inc., or realize the anticipated benefits of such acquisitions; potential business interruptions and security breaches, including cybersecurity incidents; an inability to generate sufficient working capital; increases in transportation and fuel costs and changes in our relationships with third-party suppliers; accidents, safety failures, environmental damage, product quality and liability issues and recalls; major or systemic delivery failures involving our distribution network or the products we offer; operational risks for which we may not be sufficiently insured; ongoing litigation and other legal and regulatory risks; challenges associated with international operations; exposure to interest rate and currency fluctuations; potential impairment of goodwill; liabilities associated with acquisitions, joint ventures and strategic investments; adverse developments affecting our pension plans and multi-employer pension plans; labor disruptions associated with the unionized portion of our workforce; and other factors described in the Company’s filings with the Securities and Exchange Commission. We caution you that the forward-looking information presented in this press release is not a guarantee of future events or results, and that actual events or results may differ materially from those expressed or implied by the forward-looking information contained in this press release. hurry. . In addition, forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “plans”, “seeks”, “will”, “expects”, “intends”, ” believes”, “expects”, “believes” or “continues” or their negative form or variations thereof or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unforeseen events or otherwise, except as required by law.

SOURCEUnivar Solutions Inc.

]]>